Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • BOJ Leaves Policy Intact, Bond Market Volatile
  • Sony cuts sales target for smartphones for 2014-15
  • Sirius XM: It Isn't That Confusing
  • Indian Rupee snaps initial gain vs US dollar, down 4 paise
  • Sony Cuts Games Outlook
  • 26/11: India seeks access to Rana, Headley from US
  • IPO Preview: Ply Gem Holdings
  • BSE Sensex continues to gain, IT shares lead
  • Yahoo's Transformation Into A Growth Stock...
  • How companies can copy Apple's strategy to avoid...

    Merck Pays $950M To Settle Vioxx Criminal And Civil Settlement

    Wed, 11/23/2011 - 16:42 EDT - Seeking Alpha
    • BAYZF.PK
    • MRK
    • NVS
    • The Burrill Report

    By The Burrill Report: Merck (MRK) will pay $950 million to settle criminal and civil charges related to the improper promotion and marketing of the painkiller Vioxx. The U.S. Department of Justice say Merck will pay $321.6 million in criminal fines and $628.4 as part of a civil settlement. The company also pleaded guilty to a misdemeanor charge that it marketed Vioxx for off-label use. The Justice Department said the settlement resolves allegations that Merck made false, unproven, or misleading statements about Vioxx’s safety to increase sales and made false statements to Medicaid agencies about its safety. Merck said that the settlement clear its executive management from any implications that they were involved in the violations.A federal judge thwarted Novartis’ (NVS) bid to overturn a verdict in which a jury decided the company failed to adequately warn patients that its Zometa and Aredia bone-strengthening drugs may cause severe bone damage. The ruling, madeComplete Story »

    • Original article
    • Login or register to post comments
     

    Related

    • Oil Rig Explosion Victim's Dad Says $4 Billion Criminal Fine Is 'Petty Cash To BP'

      NEW ORLEANS (AP) — Now that a $4 billion plea deal has resolved BP's criminal liability for the massive Gulf of Mexico oil spill nearly three years ago, the company will turn its focus to a trial that could potentially cost it billions of dollars more in civil penalties.

    • Rig owner reaches $1.4B settlement with Justice Department over massive Gulf Coast oil spill

      NEW ORLEANS – The U.S. Justice Department reached a US$1.4-billion settlement Thursday with Transocean Ltd., the owner of the drilling rig that sank after an explosion killed 11 workers and spawned the massive 2010 oil spill in the Gulf of Mexico.

    • Novartis to Pay $422.5 Million to Settle Allegations: Biotech's Latest Tribulations

      The Burrill Report submits: Novartis Pharmaceuticals (NVS) said it reached a $422.5 million agreement with the U.S. Attorney's Office for the Eastern District of Pennsylvania regarding civil and criminal allegations of the off-label promotion of Trileptal, as well as civil allegations relating to five other products. Novartis said the payments are in line with provisions made for a potential agreement.

    • Merck to Pay $950 Million in Vioxx Settlement

      Merck will pay $950 million to settle criminal and civil charges that it illegally promoted the painkiller Vioxx, the Justice Department announced.

    • RBS loses $US2.1-billion in market value over report of possible criminal charges in Libor settlement

      Royal Bank of Scotland Group saw 1.3-billion pounds (US$2.1-billion) wiped off its value on Tuesday following a report that it could face criminal charges as part of an impending settlement over its role in a global interest rate rigging scandal. The Wall Street Journal reported that U.S. authorities were pushing RBS to accept criminal charges as part of a settlement which will see it fined up to 500-million pounds for the attempted manipulation of the London interbank lending rate (Libor) and other benchmark interest rates.

    • Merck will pay $950M to settle Vioxx investigation

      The U.S. Department of Justice said Tuesday that drug maker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx.The agency said Merck will pay $321.6 million ...

    • J&J Pleads Guilty and Pays $85 Million to Settle Natrecor Case

      The US Justice Department announced tonight that Johnson & Johnson had pleaded guilty to a misdemeanor and had agreed to pay an $85 million criminal fine in a plea agreement to settle charges about the company?s marketing of Natrecor (nesiritide) for off-label use. The government said that Scios, the J&J subsidiary that marketed the drug, ...

    • Merck to pay $950 million to settle U.S. Vioxx charge (Reuters)

      Reuters - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

    • Merck to pay $950 million to settle U.S. Vioxx charge

      (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S.

    • Merck fined $950 mn over painkiller marketing

      Pharmaceutical giant Merck will pay nearly $1 billion to resolve criminal and civil charges for wrongfully marketing its former hit painkiller Vioxx, the US Department of Justice said.Merck agreed to plead guilty to breaking the Food Drug and Cosmetic Act after it promoted Vioxx for rheumatoid arthritis when the drug had not been approved for that disease, the department statement said in a statement.The criminal fine amounts to $321.6 million.

    Latest

    Japan reports worst April trade deficit on weak yen
    Japan reports worst April trade deficit on weak...
    Business news and markets: live
    Business news and markets: live

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Did Iceland make it through the crisis?
    • Marks & Spenser, Bank Loans in China, Vodafone and Asian Stocks in Our News for Today 05/21/2013
    • Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1669.16 0.17% FTSE: 6786.49 -0.26% Nikk.: 15627.26 1.58% DAX: 8456.37 -0.19% HSI: 23262.711 -0.45% FX: EUR/GBP: 1.172 USD/EUR: 1.2926 JPY/USD: 102.655 Commodities: Gold: 1388.75

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions